TechVision Fund, established in 2007 and based in Aachen, Germany, specializes in early-stage venture capital investments. The firm focuses on start-up companies in various sectors, including medical technology, biotechnology, pharmaceuticals, industrial software, logistics, fintech, and mobility services. Comprising engineers, developers, scientists, and business professionals, TechVision Fund emphasizes a collaborative approach, engaging closely with entrepreneurs to support their goals in strategy, product development, regulatory matters, hiring, and sales. The firm values authentic relationships and aims to invest in teams located within a two-hour reach, enabling timely and meaningful support. By providing not only capital but also strategic guidance, TechVision Fund fosters long-term partnerships with the companies it invests in, helping them grow and succeed in their respective markets.
The construction sector is the second largest, but at the same time the least digitised sector in the world with a total of 96% of all data unused. Although detailed planning data is created in advance, a lack of suitable digital tools prevents it from being transferred to the construction site. specter's web-based construction management software uniquely integrates the core components of construction planning, reduces the organisational effort for construction management, and halves construction delays.
ONIQ's IQ/A software empowers Digital Lean by automatically generating a digital process twin of manufacturing and logistics processes. IQ/A enables the holistic analysis and improvement of corporate value streams. It helps eliminating process inefficiencies, identifying root causes for quality issues and reducing the carbon footprint. IQ/A leverages IT and OT data from existing enterprise IT systems and integrates seamlessly into the existing IT infrastructure. Top 250k Enrichment Emp Range Freshness 2024 - Not Found
eeden is developing and scaling a chemical textile recycling technology. The company is tackling one of the biggest challenges in textile recycling: the efficient recovery of cellulose and polyester from polycotton blends. Their patented chemical process recovers materials that serve as seamless replacements for virgin resources in the production of high-quality clothing. By using eeden’s materials, brands can reduce their dependence on virgin resources, minimize textile waste, and meet global environmental regulations.
We are democratizing process automation. We revolutionize how companies work. 90% of employees are still burdened with boring and repetitive tasks. Automaited is building an AI model that turns proprietary process data proactively into tailored automation software in a matter of seconds. The current version enables companies to use natural language for instructing automations, making it highly accessible & user-friendly. This allows companies to deliver value fast and realize high ROIs, without engineering resources. Tackling the painful longtail of business processes.
CUREosity has the vision to revolutionize traditional rehabilitation by developing VR-based therapy applications and games to help people with neurological and mental disabilities. To do so, CUREosity provides the CE-certified medical product CUREO, which is a therapy system to support the cognitive, sensory, and motor rehabilitation. The immersion in new worlds with different scenarios and game elements motivates patients to high-frequency training and thus to fast therapy success. With CUREO, multiple patients can be cared for by just one therapist, so that clinic resources can be optimally allocated. Thomas Saur, Stefan Arand and Marco Faulhammer founded CUREosity on November 26, 2018 in Düsseldorf.
Dr. SAM connects the user with experienced veterinarians for a digital consultation. The company was founded in 2018 and based in Düsseldorf, Nordrhein-Westfalen, Germany.
We are democratizing process automation. We revolutionize how companies work. 90% of employees are still burdened with boring and repetitive tasks. Automaited is building an AI model that turns proprietary process data proactively into tailored automation software in a matter of seconds. The current version enables companies to use natural language for instructing automations, making it highly accessible & user-friendly. This allows companies to deliver value fast and realize high ROIs, without engineering resources. Tackling the painful longtail of business processes.
Taxy.io builds the leading platform for B2B tax automation. With the company's products, tax professionals in accounting firms and tax departments of SME/enterprises work better, faster and minimize compliance risks.
Product Video: https://youtu.be/RnLScgP3rxw talent::digital helps organisations upskilling their staff with the digital skills they need to succeed. Digital change requires new digital skills. With talent::digital, gaining knowledge and skills becomes a game. Employees gain new skills via bite-sized 10min long episodes delivered as a serious game. Just a few minutes every week suffice to change the digital mindset and outlook of your teams. talent::digital constantly monitors the learning activity of your teams and tests their skills to provide you with an up-to-date view of your organisation's digital skills. talent::digital stands for Upskilling that creates enthusiasm. And enthusiasm creates success! One platform - Many possibilities. - talent::digital is a cloud-based empowerment platform. - No installation, no maintenance, no hassles. - Updates and enhancements are automatically applied. - Without interrupting your business operations. You want to train your own topics? No problem. You need individual adaptations? Feel free to contact us.
Taxy.io builds the leading platform for B2B tax automation. With the company's products, tax professionals in accounting firms and tax departments of SME/enterprises work better, faster and minimize compliance risks.
ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR. The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures. Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR. Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.
Silexica was a venture capital backed company for software development tools. The SLX programming tools accelerate the journey from software to application-specific hardware systems and thus reduce time-to-market of intelligent products. Founded in 2014 as a spin-off from RWTH Aachen University, Silexica was headquartered in Germany with offices in the US and Japan. It has received $28M in venture capital funding from international investors and was acquired by Xilinx/AMD in 2021.
Adhesys Medical develops novel polyurethane-based medical adhesives for use on the skin and inside the body for a great variety of potential application areas. Due to their unique composition, they differ from existing technologies on various dimensions.
Vimecon develops and produces laser catheters for the treatment of heart diseases with a focus on atrial fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. Moreover, Vimecon advises various customers from the scholar and industrial research and development. Kai U. Markus founded it in 2005, with its headquarters in Herzogenrath in Germany.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.